dazoxiben has been researched along with Cold Fingers, Hereditary in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (83.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butendieck, RR; Murray, PM | 1 |
| Barbenel, J; Belch, JJ; Capell, H; Cormie, J; Forbes, CD; Leiberman, P; McLaren, M; Newman, P; Prentice, CR | 1 |
| Hawkey, CJ; Jones, EW | 1 |
| Hägg, A; Sandhagen, B; Wegener, T | 1 |
| Garcia, G; Luderer, JR; Neumyer, MM; Nicholas, GG; Riley, DL; Schneck, DW; Vary, JE | 1 |
| Coffman, JD; Rasmussen, HM | 1 |
| Ettinger, WH; Schaffhauser, D; Wigley, FM; Wise, RA | 1 |
| Boschetti, E; Gresele, P; Migliacci, R; Nenci, GG; Vezza, R; Volpato, R | 1 |
| Ettinger, WH; Malamet, R; Wigley, FM; Wise, RA | 1 |
| Malamet, R; Wigley, FM; Wise, RA | 1 |
| FitzGerald, GA; Pedersen, AK; Reilly, IA | 1 |
| Davies, JA; Martin, MF; Menys, VC; Tindall, H; Tooke, JE | 1 |
2 review(s) available for dazoxiben and Cold Fingers, Hereditary
| Article | Year |
|---|---|
Raynaud disease.
Topics: Calcium Channel Blockers; Cold Temperature; Delayed-Action Preparations; Enzyme Inhibitors; Female; Humans; Imidazoles; Life Style; Moxisylyte; Nifedipine; Randomized Controlled Trials as Topic; Raynaud Disease; Vasodilator Agents; Young Adult | 2014 |
The biochemical pharmacology of thromboxane synthase inhibition in man.
Topics: Clinical Trials as Topic; Epoprostenol; Humans; Imidazoles; Platelet Aggregation; Prostaglandin Endoperoxides; Raynaud Disease; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes | 1985 |
8 trial(s) available for dazoxiben and Cold Fingers, Hereditary
| Article | Year |
|---|---|
Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double-blind trial.
Topics: Adult; Body Temperature; Clinical Trials as Topic; Double-Blind Method; Female; Hand; Humans; Imidazoles; Male; Oxidoreductases; Raynaud Disease; Thromboxane-A Synthase; Time Factors | 1983 |
Blood viscosity, finger systolic pressure and effect of dazoxiben treatment in primary vasospastic disease.
Topics: Adult; Blood Viscosity; Clinical Trials as Topic; Double-Blind Method; Female; Fingers; Humans; Imidazoles; Male; Middle Aged; Myocardial Contraction; Prospective Studies; Raynaud Disease; Systole; Thromboxane-A Synthase | 1984 |
Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon.
Topics: Adult; Blood Pressure; Double-Blind Method; Drug Evaluation; Female; Fingers; Humans; Imidazoles; Male; Middle Aged; Nifedipine; Oxidoreductases; Random Allocation; Raynaud Disease; Thromboxane-A Synthase | 1984 |
Thromboxane does not play a significant role in acute, cold-induced vasoconstriction in Raynaud's phenomenon. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.
Topics: Acute Disease; Adolescent; Adult; Cold Temperature; Double-Blind Method; Female; Fingers; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Raynaud Disease; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxane-A Synthase; Vasoconstriction | 1992 |
Nifedipine in the treatment of Raynaud's phenomenon. Evidence for inhibition of platelet activation.
Topics: Adult; Arachidonic Acid; Arachidonic Acids; beta-Thromboglobulin; Blood Platelets; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Nifedipine; Placebos; Platelet Factor 4; Raynaud Disease; Thromboxane-A Synthase | 1985 |
Reproducibility of cold provocation in patients with Raynaud's phenomenon.
Topics: Adult; Cold Temperature; Double-Blind Method; Female; Fingers; Humans; Imidazoles; Lupus Erythematosus, Systemic; Male; Middle Aged; Nifedipine; Raynaud Disease; Scleroderma, Systemic | 1987 |
The biochemical pharmacology of thromboxane synthase inhibition in man.
Topics: Clinical Trials as Topic; Epoprostenol; Humans; Imidazoles; Platelet Aggregation; Prostaglandin Endoperoxides; Raynaud Disease; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes | 1985 |
Effect of dazoxiben, a thromboxane synthetase inhibitor on skin-blood flow following cold challenge in patients with Raynaud's phenomenon.
Topics: 6-Ketoprostaglandin F1 alpha; Cold Temperature; Drug Evaluation; Female; Fibrinopeptide A; Fingers; Humans; Imidazoles; Male; Random Allocation; Raynaud Disease; Regional Blood Flow; Skin; Thromboxane A2; Thromboxane-A Synthase | 1985 |
3 other study(ies) available for dazoxiben and Cold Fingers, Hereditary
| Article | Year |
|---|---|
A thromboxane synthetase inhibitor in Raynaud's phenomenon.
Topics: Adult; Body Temperature; Double-Blind Method; Epoprostenol; Female; Fingers; Humans; Imidazoles; Male; Middle Aged; Oxidoreductases; Raynaud Disease; Thromboxane A2; Thromboxane-A Synthase; Vasoconstriction | 1983 |
Dazoxiben, a thromboxane synthetase inhibitor, in Raynaud's phenomenon.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Arachidonic Acid; Arachidonic Acids; Double-Blind Method; Drug Evaluation; Female; Forearm; Humans; Imidazoles; Male; Middle Aged; Plethysmography; Radioimmunoassay; Raynaud Disease; Thromboxane B2 | 1984 |
Effect of thromboxane synthetase inhibition in Raynaud's phenomenon.
Topics: Adult; Analysis of Variance; Collagen Diseases; Double-Blind Method; Drug Evaluation; Female; Fingers; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Plethysmography; Random Allocation; Raynaud Disease; Spasm; Temperature | 1984 |